Sign Out
Epilepsy: Adults (over 12 years of age): Lamotrigine (Lamictal) is indicated for use as adjunctive or monotherapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut Syndrome.
Children (2 to 12 years of age): Lamotrigine (Lamictal) is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.
After epileptic control has been achieved during adjunctive therapy, concomitant anti-epileptic drugs (AEDs) may be withdrawn and patients continued on Lamotrigine (Lamictal) monotherapy.
Lamotrigine (Lamictal) is indicated as monotherapy in the treatment of typical absence seizures.
Bipolar Disorder: Adults (18 years of age and over): Lamotrigine (Lamictal) is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.
Continue with Google